TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
$13.79 -0.36 (-2.54%)
As of 01/27/2023 11:12:31 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.